FACULTY
DOES AN ASPIRIN A DAY
Paper Symposium
Activity Date: June 2003  — Activity Info: Volume 3, (6B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CME Activities:
As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Program Directors and Participating Faculty reported the following:

PROGRAM DIRECTORS

    A. Mark Fendrick, MD
    Associate Professor of Medicine and Health Management and Policy
    Schools of Medicine and Public Health
    University of Michigan
    Ann Arbor, Michigan
    • Dr Fendrick reports receiving grants and/or research support from Merck & Co, Inc; serving as a consultant to AstraZeneca LP, Merck & Co, Inc, Proctor & Gamble Pharmaceuticals, and TAP Pharmaceutical Products, Inc; and receiving honoraria from Proctor & Gamble Pharmaceuticals and TAP Pharmaceutical Products, Inc.

    Linda A. Lee, MD
    Assistant Professor of Medicine
    Division of Gastroenterology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Lee reports having no financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

    Uri Ladabaum, MD
    Assistant Clinical Professor of Medicine
    University of California, San Francisco School of Medicine
    San Francisco, California
    • Dr Ladabaum reports receiving grants and/or research support from AstraZeneca LP, and honoraria from GlaxoSmithKline and Novartis corporation.

    James M. Scheiman, MD
    Associate Professor of Medicine
    Division of Gastroenterology
    University of Michigan Medical Center
    Ann Arbor, Michigan
    • Dr Scheiman reports receiving grants and/or research support from AstraZeneca LP, Merck & Co, Inc, and Pfizer, Inc; serving as a consultant to AstraZeneca LP, Merck & Co, Inc, NitroMed, Inc, Novartis Corporation, Ortho-McNeil Pharmaceutical, Inc, and TAP Pharmaceutical Products, Inc; and serving on the speakers' bureau for AstraZeneca LP, Boehringer Ingelheim, Merck & Co, Inc, Pfizer, Inc, TAP Pharmaceutical Products, Inc, and Wyeth.

Notice:
In accordance with the ACCME Standards for Commercial Support, the audience is advised that one or more articles in this continuing medical education activity contains reference(s) to unlabeled or unapproved uses of drugs or devices. The following faculty member has disclosed that his article has referenced the following unlabeled/unapproved uses of drugs or products:

Dr Scheiman - Proton pump inhibitors.
All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?